Isofol Medical AB (publ)
SSE:ISOFOL.ST
0.616 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -37.071 | -159.755 | -200.251 | -188.991 | -161.583 | -83.125 | -72.035 | -64.018 | -40.688 | -10.601 |
| Depreciation & Amortization
| 0.037 | 1.642 | 1.596 | 1.77 | 1.554 | 0.157 | 0.157 | 0.132 | 0.11 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -11.054 | -31.67 | 14.767 | 24.763 | 10.215 | 1.642 | 9.935 | 6.984 | 3.811 | 0 |
| Accounts Receivables
| 21.233 | -0.504 | 9.86 | -14.05 | -3.617 | -3.66 | -0.251 | -1.351 | -0.617 | 0 |
| Inventory
| 32.287 | 31.166 | -4.907 | -38.813 | -13.832 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -32.287 | -31.166 | 4.907 | 38.813 | 13.832 | 5.302 | 10.186 | 18.471 | 0 | 0 |
| Other Working Capital
| -32.287 | -31.166 | 4.907 | 38.813 | 13.832 | 5.302 | 10.186 | 8.335 | 4.428 | 0 |
| Other Non Cash Items
| -4.448 | -1.192 | -4.541 | 2.188 | 2.606 | -11.132 | -9.621 | -15.923 | 0.001 | 10.601 |
| Operating Cash Flow
| -52.536 | -190.975 | -188.429 | -160.27 | -147.208 | -92.458 | -61.943 | -56.902 | -36.767 | 0 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | -0.324 | 0 | -0.075 | -0.073 | -0.137 | 0 |
| Acquisitions Net
| 0.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0.101 | 0 | 0 | 0.001 | -0.324 | 0 | -0.075 | -0.073 | -0.137 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | -1.704 | -1.548 | -1.553 | -1.29 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0.023 | 452.025 | 151.566 | 1.047 | 5.1 | 400.235 | 71.438 | 37.876 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.022 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -1.681 | 450.477 | 150.013 | -0.243 | 5.1 | 400.235 | -2.643 | 37.876 | 0 |
| Financing Cash Flow
| -0.05 | -1.681 | 450.477 | 150.013 | -0.243 | 5.1 | 400.235 | 68.795 | 37.876 | 0 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.05 | 3.791 | 1.007 | -0.334 | 1.861 | 2.924 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -52.385 | -188.865 | 263.055 | -10.59 | -145.914 | -84.434 | 338.217 | 11.82 | 0.972 | 0 |
| Cash At End Of Period
| 138.148 | 190.583 | 379.448 | 116.393 | 126.983 | 272.897 | 357.331 | 19.114 | 7.294 | 0 |